FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

COWARD D SCOTT
2. Date of Event Requiring Statement (MM/DD/YYYY)
12/30/2020 

3. Issuer Name and Ticker or Trading Symbol

EXACT SCIENCES CORP [EXAS]
(Last)        (First)        (Middle)

C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Administrative Officer /
(Street)

MADISON, WI 53719      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1301 D  
Common Stock 4073 I Held in 401(k) Plan 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (1) (1)Common Stock 12850  (2)D  
Restricted Stock Units  (3) (3)Common Stock 10050  (2)D  
Restricted Stock Units  (4) (4)Common Stock 9789  (2)D  
Restricted Stock Units  (5) (5)Common Stock 15888  (2)D  
Stock Option (right to buy)  (6) (6)Common Stock 18750 $21.68 D  
Stock Option (right to buy)  (7) (7)Common Stock 8350 $44.37 D  
Stock Option (right to buy)  (8) (8)Common Stock 8090 $92.62 D  
Stock Option (right to buy)  (9) (9)Common Stock 12875 $98.18 D  

Explanation of Responses:
(1) Represents a restricted stock unit award that vests in full on February 23, 2021.
(2) Each restricted stock unit represents a contingent right to receive one share of common stock.
(3) Represents a restricted stock unit award that vests in two equal annual installments beginning on February 27, 2021.
(4) Represents a restricted stock unit award that vests in three equal annual installments beginning on February 26, 2021.
(5) Represents a restricted stock unit award that vests in four equal annual installments beginning on February 14, 2021.
(6) These options vest and become exercisable in full on February 23, 2021.
(7) These options vest and become exercisable in two equal annual installments beginning on February 27, 2021.
(8) These options vest and become exercisable in three equal annual installments beginning on February 26, 2021.
(9) These options vest and become exercisable in four equal annual installments beginning on February 14, 2021.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
COWARD D SCOTT
C/O EXACT SCIENCES CORP.
5505 ENDEAVOR LANE
MADISON, WI 53719


Chief Administrative Officer

Signatures
/s/ D. Scott Coward by Mark R. Busch, attorney-in-fact1/11/2021
**Signature of Reporting PersonDate

EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more EXACT Sciences Charts.
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more EXACT Sciences Charts.